Literature DB >> 23768946

Compound heterozygous mutations of the TNXB gene cause primary myopathy.

Isabelle Pénisson-Besnier1, Valérie Allamand, Philippe Beurrier, Ludovic Martin, Joost Schalkwijk, Ivonne van Vlijmen-Willems, Corine Gartioux, Fransiska Malfait, Delfien Syx, Laurent Macchi, Pascale Marcorelles, Brigitte Arbeille, Anne Croué, Anne De Paepe, Frédéric Dubas.   

Abstract

Complete deficiency of the extracellular matrix glycoprotein tenascin-X (TNX) leads to recessive forms of Ehlers-Danlos syndrome, clinically characterized by hyperextensible skin, easy bruising and joint hypermobility. Clinical and pathological studies, immunoassay, and molecular analyses were combined to study a patient suffering from progressive muscle weakness. Clinical features included axial and proximal limb muscle weakness, subclinical heart involvement, minimal skin hyperextensibility, no joint abnormalities, and a history of easy bruising. Skeletal muscle biopsy disclosed striking muscle consistency and the abnormal presence of myotendinous junctions in the muscle belly. TNX immunostaining was markedly reduced in muscle and skin, and serum TNX levels were undetectable. Compound heterozygous mutations were identified: a previously reported 30kb deletion and a non-synonymous novel missense mutation in the TNXB gene. This study identifies a TNX-deficient patient presenting with a primary muscle disorder, thus expanding the phenotypic spectrum of TNX-related abnormalities. Biopsy findings provide evidence that TNX deficiency leads to muscle softness and to mislocalization of myotendinous junctions.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Connective tissue disorders; Ehlers–Danlos syndrome; Extracellular matrix; Myopathy; Tenascin-X

Mesh:

Substances:

Year:  2013        PMID: 23768946     DOI: 10.1016/j.nmd.2013.04.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

Review 1.  Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.

Authors:  Walter L Miller; Deborah P Merke
Journal:  Horm Res Paediatr       Date:  2018-05-07       Impact factor: 2.852

2.  High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.

Authors:  Qizong Lao; Brittany Brookner; Deborah P Merke
Journal:  J Mol Diagn       Date:  2019-06-21       Impact factor: 5.568

Review 3.  Matricellular proteins in the trabecular meshwork: review and update.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2014-06-05       Impact factor: 2.671

4.  Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia.

Authors:  Rachel Morissette; Wuyan Chen; Ashley F Perritt; Jennifer L Dreiling; Andrew E Arai; Vandana Sachdev; Hwaida Hannoush; Ashwini Mallappa; Zhi Xu; Nazli B McDonnell; Martha Quezado; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2015-06-15       Impact factor: 5.958

5.  Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice.

Authors:  Yaqun Zou; Daniela Zwolanek; Yayoi Izu; Shreya Gandhy; Gudrun Schreiber; Knut Brockmann; Marcella Devoto; Zuozhen Tian; Ying Hu; Guido Veit; Markus Meier; Jörg Stetefeld; Debbie Hicks; Volker Straub; Nicol C Voermans; David E Birk; Elisabeth R Barton; Manuel Koch; Carsten G Bönnemann
Journal:  Hum Mol Genet       Date:  2013-12-11       Impact factor: 6.150

6.  Transcriptome Analysis of Hypoxic Lymphatic Endothelial Cells Indicates Their Potential to Contribute to Extracellular Matrix Rearrangement.

Authors:  Jürgen Becker; Sonja Schwoch; Christina Zelent; Maren Sitte; Gabriela Salinas; Jörg Wilting
Journal:  Cells       Date:  2021-04-24       Impact factor: 6.600

Review 7.  Neurological manifestations of Ehlers-Danlos syndrome(s): A review.

Authors:  Marco Castori; Nicol C Voermans
Journal:  Iran J Neurol       Date:  2014-10-06

8.  Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant.

Authors:  Daisy Rymen; Marco Ritelli; Nicoletta Zoppi; Valeria Cinquina; Cecilia Giunta; Marianne Rohrbach; Marina Colombi
Journal:  Genes (Basel)       Date:  2019-10-25       Impact factor: 4.096

9.  Transcriptome profiling identifies regulators of pathogenesis in collagen VI related muscular dystrophy.

Authors:  Russell J Butterfield; Diane M Dunn; Ying Hu; Kory Johnson; Carsten G Bönnemann; Robert B Weiss
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

Review 10.  Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.

Authors:  Sanne D'hondt; Tim Van Damme; Fransiska Malfait
Journal:  Genet Med       Date:  2017-10-05       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.